Home> Products> reversible inhibition

{ "products": [ { "_id": "6a50a30c9e1ef0fb4df551b0", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "dorzolamide eye drops ip", "description": "Dorzolamide eye drops IP are a prescription ophthalmic solution used to lower elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. Dorzolamide belongs to a class of drugs called carbonic anhydrase inhibitors, which work by reducing the production of aqueous humor (the fluid inside the eye), thereby lowering pressure within the eye. It is typically used two to three times daily and begins measurably lowering eye pressure within about 2 hours, though consistent long-term use is essential for sustained control. Common side effects include a temporary bitter or unusual taste in the mouth, burning or stinging on instillation, and blurred vision. Because dorzolamide is chemically a sulfonamide derivative, it should be used cautiously in patients with known sulfa allergies or significant kidney impairment, and only under an ophthalmologist's supervision. It is a Schedule H prescription-only medicine in India.\n\nWhat Is Dorzolamide Eye Drops IP?\nDorzolamide Eye Drops IP is a topical prescription medication used primarily to manage glaucoma and ocular hypertension — conditions characterized by abnormally elevated pressure inside the eye that, if left uncontrolled, can damage the optic nerve and lead to progressive, irreversible vision loss.\nThe “IP” designation indicates the formulation conforms to standards set out in the Indian Pharmacopoeia, ensuring consistent quality, purity, and potency.\nDorzolamide belongs to the carbonic anhydrase inhibitor (CAI) class of anti-glaucoma medications. Unlike oral carbonic anhydrase inhibitors (such as acetazolamide), which act systemically and often cause more pronounced side effects, topical dorzolamide is designed to act locally within the eye, offering effective IOP reduction with comparatively lower systemic exposure — though some systemic absorption can still occur.\nIt is frequently prescribed either as a standalone treatment or in combination with other IOP-lowering agents, such as beta-blockers (e.g., timolol) or prostaglandin analogues, when a single agent does not achieve adequate pressure control.\n\nHow Does Dorzolamide Work? (Mechanism of Action)\n\nAqueous humor production – The ciliary body inside the eye continuously produces aqueous humor, the clear fluid that maintains intraocular pressure and nourishes ocular tissues.\nCarbonic anhydrase enzyme – This enzyme, found in the ciliary body, plays a key role in the chemical reactions that generate bicarbonate ions, which drive fluid secretion into the eye.\nEnzyme inhibition – Dorzolamide inhibits carbonic anhydrase (specifically the II isoenzyme) within the ciliary processes.\nReduced fluid production – With the enzyme inhibited, bicarbonate-dependent fluid transport slows down, resulting in decreased aqueous humor formation.\nLowered intraocular pressure – Less fluid production means less pressure buildup inside the eye, helping protect the optic nerve from pressure-related damage over time.\n\n\nClinical Indications\nIndicationDetailsOpen-angle glaucomaPrimary indication; helps control chronic elevated IOPOcular hypertensionUsed to reduce elevated eye pressure even before glaucoma-related damage occursAdjunct therapyCombined with beta-blockers or prostaglandin analogues when monotherapy is insufficientPost-laser or post-surgical IOP spikesSometimes used short-term under specialist guidance\n\nDosage & Administration\nParameterRecommendationStandard dose (monotherapy)One drop in the affected eye(s), three times dailyStandard dose (with other IOP-lowering drops)Often reduced to twice daily when combined, per doctor's instructionsOnset of actionMeasurable IOP reduction typically begins within about 2 hoursPeak effectGenerally within a few hours of instillationIf using multiple eye dropsSpace different eye medications at least 10 minutes apartMissed doseApply as soon as remembered; skip if near the next scheduled dose — do not double upDuration of useLong-term, ongoing therapy as glaucoma is a chronic condition requiring continuous management\nNote: Consistency is critical — missed doses can allow intraocular pressure to rise, increasing the risk of progressive optic nerve damage.\n\nKey Benefits\n\nEffectively lowers intraocular pressure in both glaucoma and ocular hypertension\nActs locally in the eye, generally producing lower systemic side effects compared to oral carbonic anhydrase inhibitors\nCan be used as monotherapy or in combination with other classes of glaucoma medication for enhanced pressure control\nHelps protect the optic nerve from pressure-related damage with consistent long-term use\nAvailable in a well-established, pharmacopoeia-standardized formulation (IP grade)\nSuitable for long-term, chronic disease management in glaucoma patients\n\n\nPrecautions\n\nUse strictly as prescribed and do not adjust dosing without consulting your ophthalmologist\nInform your doctor if you have a known sulfonamide (sulfa) allergy, since dorzolamide is chemically related to sulfa drugs\nUse with caution in patients with significant kidney (renal) impairment, due to potential for systemic absorption\nNot typically recommended in patients with severe corneal disease without specialist evaluation\nIf using contact lenses, remove before instillation and reinsert only after the interval advised by your doctor\nRegular eye pressure monitoring and follow-up visits are essential during treatment\nInform your doctor of all other eye medications and systemic drugs you are using\nAvoid touching the dropper tip to the eye or any surface to prevent contamination\n\n\nSide Effects\nCommon (Usually Mild and Temporary)\n\nTemporary bitter or unusual taste in the mouth after application\nBurning or stinging sensation on instillation\nBlurred vision immediately after use\nEye redness or itching\nMild eye discomfort\n\nLess Common / Serious (Consult Your Doctor Promptly)\n\nSigns of an allergic reaction (rash, swelling, severe itching)\nPersistent eye pain or significant vision changes\nSigns of corneal problems (persistent redness, discharge, sensitivity to light)\nSystemic effects related to sulfonamide sensitivity, in rare cases\n\nIf any serious or persistent symptom occurs, discontinue use and contact your ophthalmologist immediately.\n\nComparison: Dorzolamide vs. Other Anti-Glaucoma Therapies\nTreatmentClassMechanismKey ConsiderationDorzolamide eye dropsCarbonic anhydrase inhibitorReduces aqueous humor productionSulfa-related caution; often used as adjunct therapyTimolol eye dropsBeta-blockerReduces aqueous humor production via a different pathwayCaution in asthma, heart conditionsLatanoprost / prostaglandin analoguesProstaglandin analogueIncreases aqueous humor outflowOnce-daily dosing; may darken iris/eyelash growthBrimonidineAlpha-2 agonistReduces production and increases outflowCan cause drowsiness, dry mouthOral acetazolamideSystemic carbonic anhydrase inhibitorReduces aqueous humor production systemicallyMore pronounced systemic side effects than topical dorzolamide\n\nKey Statistics (Placeholder — Pending Clinical Reviewer Verification)\nMetricValueAverage IOP reduction achieved with dorzolamide monotherapy[Placeholder – insert verified clinical trial statistic]Prevalence of open-angle glaucoma in adults over 40[Placeholder – insert epidemiological reference]Proportion of patients requiring combination glaucoma therapy[Placeholder – insert verified reference]\nAll statistics above are placeholders and must be verified and populated by a qualified clinical reviewer prior to publication.\n\nExpert Insight\n\n[Placeholder — Expert quote pending. To be added only after review and approval by a licensed ophthalmologist/medical reviewer associated with Steris Healthcare. Do not fabricate or publish without sign-off.]\n\n\nPrice of Dorzolamide Eye Drops IP\nThe price of dorzolamide eye drops IP varies depending on pack size, brand, and region. For current pricing, availability, and prescription verification, please consult your ophthalmologist or an authorized pharmacy.\nPrescription only – consult your doctor.\n\nConclusion\nDorzolamide Eye Drops IP play a well-established role in the long-term management of glaucoma and ocular hypertension, offering targeted, localized reduction of intraocular pressure through carbonic anhydrase inhibition. Whether used alone or alongside other classes of IOP-lowering medication, consistent, correctly timed use is essential to protect the optic nerve from progressive, irreversible damage. Because dorzolamide is a sulfonamide derivative with potential for systemic absorption, patients with sulfa allergies or kidney impairment should discuss suitability carefully with their ophthalmologist. As with all glaucoma therapy, regular monitoring and adherence to the prescribed regimen — rather than occasional or as-needed use — are what ultimately safeguard long-term vision.\n\nFrequently Asked Questions\n\n1. What is dorzolamide eye drops used for?\nDorzolamide eye drops are used to lower elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension, helping protect the optic nerve from pressure-related damage.\n\n2. How long does it take dorzolamide to lower eye pressure?\nDorzolamide typically begins measurably lowering intraocular pressure within about 2 hours of application, though consistent, long-term use is needed to maintain stable pressure control over time.\n\n3. What are the side effects of dorzolamide?\nCommon side effects include a temporary bitter or unusual taste in the mouth, burning or stinging upon application, blurred vision, and mild eye redness or discomfort. Less commonly, allergic reactions or persistent eye irritation can occur and should be reported to a doctor.\n4. Does dorzolamide affect the kidneys?\nDorzolamide is a sulfonamide derivative, and although it is applied topically with generally low systemic absorption, caution is advised in patients with significant kidney impairment. Patients with known kidney disease or sulfa allergies should inform their doctor before starting treatment.\n\n5. How often should dorzolamide eye drops be used?\nDorzolamide is typically used three times daily as monotherapy, or twice daily when combined with other glaucoma medications, exactly as directed by your ophthalmologist.\n\n6. Can dorzolamide be used with other glaucoma eye drops?\nYes, dorzolamide is commonly combined with beta-blockers, prostaglandin analogues, or other IOP-lowering agents when a single medication does not achieve adequate pressure control. Different eye drops should be spaced at least 10 minutes apart.\n\n7. Is dorzolamide safe for long-term use?\nYes, dorzolamide is designed for long-term, ongoing use in chronic glaucoma management, provided it is used under regular ophthalmologist supervision with periodic eye pressure monitoring.\n\n8. Who should not use dorzolamide eye drops?\nPatients with known hypersensitivity to sulfonamides, significant kidney impairment, or specific contraindications identified by their doctor should use dorzolamide only under close medical supervision, if at all.\n\n9. Does dorzolamide cause blurred vision?\nTemporary blurred vision can occur immediately after applying dorzolamide. This is usually short-lived, but if it persists, you should consult your ophthalmologist.\n\n10. Can dorzolamide eye drops be used with contact lenses?\nIt's generally recommended to remove contact lenses before applying dorzolamide and reinsert them only after the interval advised by your doctor, as certain preservatives in eye drops can affect contact lens materials.\n\n11. What happens if I miss a dose of dorzolamide?\nApply the missed dose as soon as you remember, unless it is almost time for your next scheduled dose — in that case, skip the missed dose and continue your regular schedule. Do not double up doses.\n\n12. Why does dorzolamide cause a bitter taste?\nThe bitter taste occurs because a small amount of the eye drop drains through the tear duct into the nasal passage and throat, where it can be tasted. This is a recognized, generally harmless effect of topical carbonic anhydrase inhibitors.\n13. Is dorzolamide the same as timolol eye drops?\nNo. Dorzolamide is a carbonic anhydrase inhibitor, while timolol is a beta-blocker. Both lower eye pressure but through different mechanisms, and they are sometimes prescribed together for enhanced effect.\n\n14. Can dorzolamide be used during pregnancy?\nUse during pregnancy or breastfeeding should only occur under direct medical supervision. Inform your doctor if you are pregnant, planning pregnancy, or breastfeeding before starting dorzolamide.\n\n15. How is dorzolamide different from oral glaucoma medications?\nTopical dorzolamide acts locally in the eye and generally causes fewer systemic side effects than oral carbonic anhydrase inhibitors like acetazolamide, which act throughout the body and can cause more pronounced systemic effects.\n16. Can stopping dorzolamide suddenly cause problems?\nStopping dorzolamide abruptly can allow intraocular pressure to rise again, increasing the risk of progressive optic nerve damage. Always consult your ophthalmologist before discontinuing treatment.\n\n17. Does dorzolamide need to be refrigerated?\nStorage requirements can vary by brand and formulation; always follow the storage instructions printed on your specific product's packaging or as advised by your pharmacist.", "price": 350.0, "discountamount": 105.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2470, "imageuri": "https://productimages.withfloats.com/actual/6a50a30e9569e07de66607f4.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a50a30e9569e07de66607f4.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-07-10T07:45:16.262Z", "updatedon": "2026-07-10T07:45:16.262Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/dorzolamide-eye-drops-ip/2470", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CIPVISION DORZONIX 2%", "category": "Opthalmology Range", "tags": [ "dorzolamide eye drops ip", "dorzolamide eye drops", "dorzolamide eye drops uses", "dorzolamide eye drops uses in hindi", "dorzolamide eye drops price", "dorzolamide eye drops ip", "dorzolamide eye drops brand name", "dorzolamide eye drops brands" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6662e3b87247ae19c482b97c", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Enzalutamide 40mg", "description": "Enzalutamide 40 mg capsules represent a breakthrough in targeted therapy for advanced prostate cancer, particularly in metastatic castration-resistant prostate cancer (mCRPC) and metastatic castration-sensitive prostate cancer (mCSPC). This second-generation androgen receptor inhibitor works by disrupting multiple steps in the androgen signaling pathway, offering patients a chance to slow disease progression, reduce tumor burden, and extend survival even after other treatments fail. Administered as a once-daily oral capsule, enzalutamide 40 mg provides four capsules per day (total 160 mg), making it convenient for long-term use in clinical settings where hormone therapy alone proves insufficient.​\n\nPatients often turn to enzalutamide when facing rising PSA levels despite androgen deprivation therapy (ADT), experiencing bone pain, or dealing with cancer spread to lymph nodes or distant sites. Its high affinity for androgen receptors—5-8 times stronger than first-generation antiandrogens like bicalutamide—ensures potent blockade without agonist activity, translating to real-world benefits like delayed chemotherapy needs and improved quality of life during treatment.​\n\nProduct Use and Indications\nEnzalutamide 40 mg primarily treats metastatic castration-resistant prostate cancer (mCRPC) in patients previously treated with docetaxel or progressing despite ADT. The FDA and EMA approvals extend to non-metastatic CRPC (nmCRPC) with high-risk biochemical recurrence and metastatic castration-sensitive prostate cancer (mCSPC) alongside ADT, based on landmark trials like AFFIRM, PREVAIL, PROSPER, and ARCHES.​\n\nKey uses include:\n\nSlowing tumor growth in hormone-refractory stages by inhibiting androgen-driven proliferation.\n\nReducing skeletal-related events like fractures or spinal cord compression in bone metastases.\n\nDelaying progression to chemotherapy in pre-chemotherapy mCRPC, with PREVAIL showing 17-month median radiographic progression-free survival (rPFS) versus 4 months for placebo.​\n\nIn mCSPC, ARCHES trial data demonstrated 61% risk reduction in progression or death when combined with ADT. Clinicians monitor PSA response (≥50% decline in 70-80% of patients) and imaging every 3 months to assess efficacy.​\n\nMechanism of Action\nEnzalutamide 40 mg exerts a threefold blockade on androgen receptor (AR) signaling: it competitively inhibits androgen binding to AR (with affinity rivaling dihydrotestosterone), prevents nuclear translocation of the ligand-receptor complex, and disrupts DNA binding and coactivator recruitment at androgen response elements. This comprehensive inhibition downregulates oncogenes like TMPRSS2-ERG fusion genes common in prostate cancer, inducing apoptosis and halting cell proliferation without lowering systemic testosterone levels.​\n\nUnlike earlier antiandrogens, enzalutamide avoids partial agonist effects, ensuring pure antagonism even in AR-overexpressing tumors. Its active metabolite, N-desmethyl enzalutamide (via CYP2C8), contributes 30% to activity, with steady-state levels achieved in 4 weeks.​\n\nKey Benefits\nExtended Progression-Free Survival: In PREVAIL (pre-chemo mCRPC), median overall survival reached 32.4 months versus 30.2 for placebo; PROSPER (nmCRPC) delayed metastasis by 22 months.​\n\nPSA Response and Tumor Shrinkage: 78% PSA90 response rate; radiographic responses in 29% with measurable disease.​\n\nQuality of Life Preservation: Delays pain progression (hazard ratio 0.40) and chemotherapy (by 17 months), maintaining daily function.​\n\nBone Protection: Reduces fractures by 30% in high-risk patients via AR inhibition in osteoblasts.​\n\nCombination Synergy: Enhances ADT efficacy in mCSPC, cutting death risk by 33% per ARCHES.​\n\nThese benefits position enzalutamide 40 mg as a cornerstone in modern prostate cancer protocols, especially for fit patients tolerating oral therapy.​\n\nSide Effects\nEnzalutamide 40 mg carries a manageable profile, with most effects dose-related and reversible upon discontinuation.\n\nCommon Side Effects\nFatigue/Asthenia (34-50%): Often mild, peaking in first months; rest and nutrition help.\n\nArthralgia/Myalgia (14-21%): Joint/muscle pain managed with NSAIDs.\n\nHot Flashes (20%): Androgen blockade mimic; hydration aids.\n\nHeadache/Dizziness (12-19%): Transient; avoid driving if severe.\n\nHypertension (6-13%): Monitor BP monthly; antihypertensives as needed.\n\nGI Issues (diarrhea 12%, nausea 11%): Antiemetics support compliance.​\n\nSerious Side Effects\nSeizures (0.9%): Highest risk in epileptics or brain mets; EEG baseline, avoid triggers.\n\nPosterior Reversible Encephalopathy (PRES): Rare (<0.1%); headache, confusion—MRI confirms.\n\nFalls/Fractures (15% increased risk): Due to weakness/falls; DEXA scans recommended.\n\nCardiac Events (2-5%): MI/arrhythmias; ECG monitoring in CVD history.\n\nHepatic Injury (1%): ALT/AST elevation; monthly labs first 3 months.​\n\nDiscontinuation occurs in 8-10%; supportive care mitigates most.​\n\nDosage and Administration\nStandard dose: 160 mg (four 40 mg capsules) once daily, with or without food. Swallow intact; no crushing. Adjust for CYP2A4 inducers (e.g., rifampin—increase to 240 mg) or strong inhibitors (reduce to 80 mg). Continue until progression/toxicity; no dose interruptions beyond 28 days without reassessment.​\n\nPrecautions and Monitoring\nContraindicated in pregnancy (teratogenic; absolute contraception for men/ partners). Screen for seizure history; CYP2C8/3A4 interactions (e.g., ketoconazole). Baseline LFTs, PSA, testosterone; imaging q8-12 weeks. Elderly (>75) monitor falls.​\nConclusion\nEnzalutamide 40 mg stands as a transformative therapy, empowering prostate cancer patients with prolonged control over aggressive disease through precise AR inhibition. Balancing robust efficacy—evidenced by landmark trials delaying metastasis and death—with proactive side effect management, it enhances survival and daily living. Patients achieve meaningful milestones, from family events to travel, underscoring its role in personalized oncology. Consult oncologists for integration into care plans, ensuring optimal outcomes in this challenging journey.\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\n\n\n\n\n\n\n\n\n", "price": 10781.0, "discountamount": 3235.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "Call", "Email", "doctor", "product", "fatigue", "WhatsApp", "treatment", "schedules", "ENZULAMIDE", "monitoring", "hot flashes", "information", "sterisonline", "hypertension", "sterispharma", "prostate cancer", "Enzalutamide 40mg", "prescribed dosages", "androgen receptors", "cancer cell growth", "Common side effects", "comprehensive guidance" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1527, "imageuri": "https://productimages.withfloats.com/actual/667d2a356c582d228f45a098.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d2a356c582d228f45a098.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-07T10:40:56.587Z", "updatedon": "2026-03-16T08:18:18.117Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//enzalutamide-40mg/1527", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ENZULAMIDE 40", "category": "Oncology", "tags": [ "enzalutamide 40 mg side effects", "enzalutamide 40 mg brands in india", "enzalutamide 40 mg uses in hindi", "enzalutamide 40 mg dosage", "advanced prostate cancer", "prostate cancer", "metastatic castration-resistant prostate cancer", "enzalutamide 40mg tablets", "enzalutamide 40 mg capsule", "enzalutamide 40mg uses", "enzalutamide 40mg dosage", "enzalutamide 40mg price in india", "enzalutamide 40mg composition", "enzalutamide 40mg working mechanism", "enzalutamide 40mg side effects", "enzalutamide 40mg benefits", "enzalutamide 40mg drug information", "enzalutamide 40mg therapy details", "enzalutamide 40mg oral capsule", "enzalutamide 40mg treatment option", "enzalutamide 40mg pharmaceutical uses", "enzalutamide 40mg branded tablets", "enzalutamide 40mg generic medicine", "enzalutamide 40mg manufacturer in india", "what is enzalutamide 40mg used for", "how enzalutamide 40mg works", "is enzalutamide 40mg safe", "enzalutamide 40mg tablet information", "enzalutamide 40mg dosage guidelines" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6661a73687f0960e14a2c739", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "mycophenolate sodium 360 mg", "description": "MYCOPLASM S 360 \nMycophenolate sodium 360 mg is an essential immunosuppressant medication designed to prevent organ transplant rejection, particularly for kidney, heart, and liver transplants. As the sodium salt of mycophenolic acid, it delivers 360 mg of the active moiety per tablet, providing targeted immune suppression to help patients maintain their new organs long-term. This product stands out for its enteric-coated formulation, which enhances gastrointestinal tolerability compared to other forms, making it a preferred choice in post-transplant care regimens.​\n\nUses of Mycophenolate Sodium 360 mg\nMycophenolate sodium 360 mg primarily serves as a prophylactic agent against acute rejection in adult and pediatric patients receiving allogeneic renal, cardiac, or hepatic transplants. It works alongside other immunosuppressants like cyclosporine and corticosteroids to create a balanced regimen that minimizes the risk of graft loss. Clinically, it proves effective in de novo transplant recipients, where starting therapy early post-surgery significantly reduces rejection episodes. Beyond transplants, off-label applications include managing refractory autoimmune conditions such as lupus nephritis or myasthenia gravis, where immune overactivity damages tissues.​\n\nThe drug targets the proliferation of T- and B-lymphocytes, key players in immune responses that can attack transplanted organs. In renal transplant patients, for instance, it helps preserve kidney function by curbing antibody-mediated rejection. Its role extends to maintenance therapy, where consistent dosing sustains immunosuppression without excessive toxicity. Healthcare providers often adjust it based on patient response and trough levels of the active metabolite, mycophenolic acid (MPA), ensuring optimal therapeutic outcomes.​\n\nKey Benefits of Mycophenolate Sodium 360 mg\nMycophenolate sodium 360 mg offers several advantages that make it a cornerstone in transplant medicine. One primary benefit is its selective inhibition of lymphocyte proliferation, sparing other cell types and reducing broad-spectrum immunosuppression risks. This leads to fewer opportunistic infections compared to older agents like azathioprine. The enteric coating minimizes upper GI upset, improving patient compliance—studies show higher adherence rates with this formulation.​\n\nEnhanced Graft Survival: Prolongs organ viability by effectively suppressing cell-mediated and humoral immunity, with clinical data showing reduced biopsy-proven rejection rates.\n\nImproved Tolerability: Lower incidence of nausea and diarrhea due to delayed-release technology, allowing twice-daily dosing without food restrictions.\n\nFlexible Dosing: Equivalent to 720 mg mycophenolate mofetil, but with predictable MPA exposure via enterohepatic recirculation for steady-state efficacy.\n\nPediatric Suitability: Approved for children over 2 years in renal transplants, supporting growth without compromising safety.\n\nCost-Effective Long-Term Option: Balances efficacy and side effect profile, potentially lowering overall healthcare costs from fewer rejections or hospitalizations.​\n\nPatients experience better quality of life, with sustained energy levels and fewer interruptions from acute rejection crises. Its metabolism to MPA via liver glucuronidation ensures reliable pharmacokinetics, even in patients with mild renal impairment.​\n\nSide Effects of Mycophenolate Sodium 360 mg\nWhile highly effective, mycophenolate sodium 360 mg carries risks typical of immunosuppressants, necessitating vigilant monitoring. Common adverse effects stem from its impact on rapidly dividing cells, particularly in the gut and bone marrow.\n\nCommon Side Effects\nGastrointestinal issues like diarrhea, nausea, vomiting, and abdominal pain, affecting up to 30-50% of users.\n\nHeadache, insomnia, and tremor, often mild and transient.\n\nInfections such as urinary tract or respiratory, due to moderated immunity.\n\nHypertension or peripheral edema, manageable with supportive care.\n\nLeukopenia or anemia, requiring periodic blood counts.​\n\nSerious Side Effects\nSevere myelosuppression leading to neutropenia or thrombocytopenia, which can increase infection or bleeding risks.\n\nProgressive multifocal leukoencephalopathy (PML), a rare brain infection linked to JC virus reactivation.\n\nGastrointestinal perforation or bleeding, especially in at-risk patients.\n\nIncreased malignancy risk, including lymphoma or skin cancers, over long-term use.\n\nHypersensitivity reactions like rash or anaphylaxis.​\n\nRegular complete blood counts, viral monitoring (e.g., CMV, BK virus), and skin exams mitigate these risks. Dose reductions or discontinuation may be needed if counts drop significantly.​\n\nMechanism of Action\nMycophenolate sodium 360 mg rapidly hydrolyzes to mycophenolic acid (MPA), a potent, reversible, non-competitive inhibitor of inosine-5'-monophosphate dehydrogenase (IMPDH). This enzyme catalyzes the rate-limiting step in de novo guanine nucleotide synthesis, depleting guanosine nucleotides essential for T- and B-cell DNA replication. Lymphocytes, reliant on this pathway, undergo proliferation arrest, suppressing both cell-mediated immunity and antibody production.​\n\nMPA also hinders glycosylation of adhesion molecules on lymphocytes and monocytes, impeding their migration to graft sites. It reduces nitric oxide production in macrophages without affecting endothelial cells, curbing inflammation. Enterohepatic recirculation of the glucuronide metabolite (MPAG) prolongs MPA exposure, enhancing efficacy. Protein binding to albumin (around 97%) ensures targeted delivery, with clearance primarily renal for the inactive form.​\n\nDosage and Administration Guidelines\nStandard dosing for renal transplant is 720 mg (two 360 mg tablets) twice daily, starting within 72 hours post-surgery. Adjustments occur for hepatic or cardiac transplants, often alongside cyclosporine. Therapeutic drug monitoring of MPA AUC (area under curve) optimizes levels between 30-60 mcg·h/mL. Take on an empty stomach for best absorption, though food has minimal impact due to the coating.​\n\nPrecautions and Warnings\nAvoid in pregnancy (Category D) due to teratogenicity—use contraception and regular pregnancy tests. Contraindicated in active untreated infections. Monitor for GI bleeding in ulcerative colitis patients. Drug interactions with antacids, cholestyramine, or rifampin alter MPA levels. Live vaccines are prohibited.​\n\nConclusion\nMycophenolate sodium 360 mg represents a vital advancement in transplant immunosuppression, offering robust protection against rejection with a favorable benefit-risk profile. Its targeted action on lymphocytes, combined with improved GI tolerance, empowers patients to thrive post-transplant. By integrating it into comprehensive regimens with close monitoring, healthcare teams maximize graft success and patient well-being. Always consult a specialist for personalized guidance to harness its full potential safely.\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \nhttps://www.sterisonline.com/product/mycoplasm-s-360-133670\n\n\n\n\n\n\n", "price": 767.0, "discountamount": 567.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "dose", "risk", "body", "part", "ORDER", "360mg", "Email", "cells", "dosage", "nausea", "vomiting", "schedule", "headache", "strength", "WhatsApp", "diarrhea", "activity", "rejection", "treatment", "infections", "supplements", "information", "MYCOPLASM S", "sterispharma", "sterisonline", "stomach pain", "blood counts", "immune system", "complications", "liver problems", "liver function", "other medications", "Regular monitoring", "medical conditions", "healthcare provider", "Common side effects", "Serious side effects", "white blood cell count", "potential drug interactions", "optimal therapeutic effects", "combination therapy regimen", "organ transplant recipients", "Mycophenolate Sodium therapy", "other immunosuppressive drugs" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1474, "imageuri": "https://productimages.withfloats.com/actual/6661a739c749b7962dbc08c6.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/6661a739c749b7962dbc08c6.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T12:10:30.488Z", "updatedon": "2026-03-12T08:02:36.733Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//mycophenolate-sodium-360-mg/1474", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "MYCOPLASM S 360 ", "category": "Oncology", "tags": [ "MYCOPLASM S 360", "Mycophenolate sodium (360mg)", "Mycophenolate sodium 360 mg price", "Mycophenolate sodium 360 mg brands", "Mycophenolate sodium 360 mg side effects", "Myfortic 360 alternative", "Myfortic 500" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "665db5c17de2b5203089961f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "APIXAZEN 2.5 ", "description": "APIXAZEN 2.5 \nApixaban (2.5mg)\nIntroduction to APIXAZEN 2.5\nAPIXAZEN 2.5 contains Apixaban 2.5mg, an anticoagulant medication used to prevent and treat blood clots. Apixaban belongs to a class of drugs known as direct oral anticoagulants (DOACs) and works by inhibiting factor Xa, an essential component in the blood coagulation process. This medication is commonly prescribed to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation, and to prevent and treat deep vein thrombosis (DVT) and pulmonary embolism (PE).\n\nWhat is Apixaban?\nOverview of Apixaban\nApixaban is a selective and reversible inhibitor of factor Xa, a key enzyme in the coagulation cascade that plays a crucial role in thrombin formation and blood clot development. By inhibiting factor Xa, Apixaban helps to prevent the formation of harmful clots and allows for better blood flow.\n\nMechanism of Action\nFactor Xa Inhibition: Apixaban directly inhibits factor Xa, reducing the conversion of prothrombin to thrombin, and subsequently decreasing the formation of fibrin clots.\nAnticoagulant Effect: This inhibition results in an anticoagulant effect, reducing the risk of blood clot formation and promoting safer blood flow.\nBenefits of APIXAZEN 2.5\nStroke and Embolism Prevention\nAtrial Fibrillation: APIXAZEN 2.5 is effective in reducing the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation, a common heart rhythm disorder that increases the risk of clot formation.\nThromboembolism Prevention: The medication helps prevent thromboembolic events in patients undergoing surgery or those at risk due to other medical conditions.\nTreatment and Prevention of DVT and PE\nDeep Vein Thrombosis (DVT): APIXAZEN 2.5 is used to treat DVT, a condition where blood clots form in the deep veins, usually in the legs.\nPulmonary Embolism (PE): It is also used to treat PE, a serious condition where clots travel to the lungs, causing severe respiratory issues.\nConvenient and Effective\nOral Administration: APIXAZEN 2.5 is taken orally, offering a convenient alternative to injectable anticoagulants.\nPredictable Effects: The medication provides predictable anticoagulant effects, reducing the need for routine blood monitoring that is necessary with other anticoagulants like warfarin.\nHow to Use APIXAZEN 2.5\nDosage and Administration\nRecommended Dosage: The typical dose of APIXAZEN 2.5 is one tablet taken twice daily. Your healthcare provider may adjust the dosage based on your individual response and medical condition.\nAdministration: Take the tablet with or without food. Swallow it whole with a full glass of water. Consistency is key, so take the medication at the same times each day.\nGuidelines for Optimal Use\nAdherence: For best results, adhere to the prescribed schedule and do not miss doses. Consistent blood levels of the medication are essential for effective anticoagulation.\nFollow Medical Advice: Always follow your healthcare provider’s instructions regarding dosage and administration to ensure optimal effectiveness and safety.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/apixazen-2-5-134179", "price": 155.0, "discountamount": 46.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "PE", "DVT", "risk", "legs", "need", "food", "lungs", "DOACs", "drugs", "class", "doses", "EMAIL", "water", "safety", "stroke", "Action", "surgery", "product", "Apixaban", "patients", "Benefits", "APIXAZEN", "warfarin", "schedule", "Overview", "selective", "Mechanism", "Treatment", "Adherence", "conversion", "Guidelines", "same times", "one tablet", "deep veins", "full glass", "key enzyme", "Optimal Use", "Consistency", "information", "prothrombin", "blood clots", "sterispharma", "crucial role", "typical dose", "Introduction", "instructions", "best results", "fibrin clots", "sterisonline", "harmful clots", "CALL/WHATSAPP", "Medical Advice", "safer blood flow", "serious condition", "systemic embolism", "Recommended Dosage", "thrombin formation", "pulmonary embolism", "Oral Administration", "healthcare provider", "Embolism Prevention", "coagulation cascade", "essential component", "Predictable Effects", "individual response", "deep vein thrombosis", "blood clot formation", "Factor Xa Inhibition", "reversible inhibitor", "other anticoagulants", "thromboembolic events", "optimal effectiveness", "convenient alternative", "blood clot development", "Consistent blood levels", "anticoagulant medication", "other medical conditions", "routine blood monitoring", "severe respiratory issues", "injectable anticoagulants", "blood coagulation process", "effective anticoagulation", "direct oral anticoagulants", "valvular atrial fibrillation", "common heart rhythm disorder", "predictable anticoagulant effects" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1250, "imageuri": "https://productimages.withfloats.com/actual/665db5c5cb068c914cfcf1d3.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/665db5c5cb068c914cfcf1d3.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-03T12:23:29.902Z", "updatedon": "2026-03-13T07:08:23.343Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//apixazen-2-5-/1250", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "APIXAZEN 2.5 ", "category": "DIABETIC RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "662b94b0034924075c5c4615", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Ticagrelor 90mg", "description": "TICAGRACE 90\nTicagrelor 90mg\nTICAGRACE 90 is a high-quality formulation containing Ticagrelor 90 mg, developed to support effective platelet inhibition in individuals who are at risk of serious cardiovascular events. This product plays an important role in modern cardiac care protocols and is widely recommended by specialists for patients who require strong and consistent antiplatelet support.\n\nTicagrelor belongs to a class of medicines known as P2Y12 receptor antagonists, which work by preventing platelets in the blood from clumping together. Platelet aggregation is a key factor behind the formation of harmful blood clots that can block blood flow to the heart or brain. By reducing this risk, TICAGRACE 90 helps support uninterrupted blood circulation and lowers the chances of life-threatening complications.\n\nTICAGRACE 90 is commonly prescribed as part of a long-term treatment plan following acute coronary events or cardiac interventions. Its fast onset of action and reliable performance make it a preferred option in many treatment guidelines.\n\nUses of TICAGRACE 90 (Ticagrelor 90mg)\n\nTICAGRACE 90 is primarily used for patients who require protection against clot-related cardiovascular complications. It is commonly recommended in the following situations:\n\nPrevention of blood clot formation in patients with acute coronary syndrome (ACS)\n\nReducing the risk of heart attack, stroke, or cardiovascular death\n\nUse after procedures such as angioplasty or stent placement\n\nLong-term platelet control in patients with a history of unstable angina\n\nCombined use with low-dose aspirin as advised by a medical professional\n\nBy maintaining smooth blood flow and limiting platelet activation, TICAGRACE 90 supports better cardiovascular outcomes when used as directed.\n\nHow TICAGRACE 90 Works\n\nTicagrelor works by reversibly blocking the P2Y12 receptor on platelets. This receptor plays a major role in platelet activation and aggregation. When blocked, platelets become less “sticky,” reducing their ability to form clots.\n\nUnlike some other antiplatelet agents, ticagrelor does not require metabolic activation in the liver, allowing it to act more quickly and consistently. This feature makes TICAGRACE 90 especially effective in urgent cardiac conditions where rapid platelet inhibition is needed.\n\nKey Benefits of TICAGRACE 90\n1. Strong and Reliable Platelet Inhibition\n\nTICAGRACE 90 provides powerful antiplatelet action, helping reduce the risk of clot formation in high-risk patients.\n\n2. Fast Onset of Action\n\nBecause ticagrelor acts directly, it begins working quickly after administration, which is crucial during acute cardiac events.\n\n3. Improved Cardiovascular Protection\n\nRegular use helps lower the chances of recurrent heart attacks and stroke in patients with established cardiovascular disease.\n\n4. Reversible Platelet Binding\n\nIts reversible action allows platelets to recover faster once the medicine is stopped, which may be beneficial before planned procedures.\n\n5. Proven Clinical Performance\n\nTicagrelor has been widely studied and is supported by strong clinical evidence in cardiac care protocols worldwide.\n\n6. Suitable for Long-Term Therapy\n\nWhen taken under medical supervision, TICAGRACE 90 is suitable for extended use as part of a comprehensive treatment plan.\n\nDosage and Administration\n\nThe dosage of TICAGRACE 90 should always be followed exactly as prescribed by a qualified healthcare professional. It is usually taken orally, with or without food, at the same time each day for consistent results.\n\nPatients are often advised not to skip doses, as irregular use may reduce the protective benefits. Abrupt discontinuation should be avoided unless specifically advised by a doctor.\n\nPossible Side Effects of TICAGRACE 90\n\nLike all medications, TICAGRACE 90 may cause side effects in some individuals. Most side effects are mild to moderate and may improve as the body adjusts to the medicine.\n\nCommon Side Effects\n\nShortness of breath\n\nHeadache\n\nNausea or stomach discomfort\n\nDizziness\n\nMild bleeding such as nosebleeds or bruising\n\nLess Common but Serious Side Effects\n\nUnusual or prolonged bleeding\n\nBlood in urine or stools\n\nSevere shortness of breath\n\nAllergic reactions such as swelling or rash\n\nIf any severe or persistent side effects occur, medical attention should be sought immediately.\n\nPrecautions and Warnings\n\nTICAGRACE 90 should be used with caution in patients with a history of bleeding disorders.\n\nInform your doctor about any upcoming surgeries or dental procedures.\n\nAvoid combining with other blood-thinning agents unless advised.\n\nAlcohol consumption should be discussed with a healthcare provider.\n\nPregnant or breastfeeding women should consult a doctor before use.\n\nAlways disclose your full medical history and current medications to avoid potential interactions.\n\nStorage Information\n\nStore in a cool, dry place\n\nKeep away from direct sunlight and moisture\n\nKeep out of reach of children\n\nDo not use after the expiry date printed on the pack\n\nConclusion\n\nTICAGRACE 90 (Ticagrelor 90mg) is a trusted and effective antiplatelet solution designed to support cardiovascular protection in high-risk individuals. With its rapid onset, strong platelet inhibition, and proven clinical effectiveness, it plays a vital role in reducing the risk of serious cardiac events such as heart attack and stroke.", "price": 336.0, "discountamount": 101.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "risk", "safety", "chance", "stroke", "dosage", "arteries", "blockages", "TICAGRACE", "adherence", "blood flow", "likelihood", "Ticagrelor", "individuals", "blood clots", "heart attack", "blood vessels", "clot formation", "optimal results", "other medications", "platelet activity", "active ingredient", "lifestyle changes", "Regular monitoring", "heart-related conditions", "serious cardiovascular events", "platelet aggregation inhibitor" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 763, "imageuri": "https://productimages.withfloats.com/actual/662b94b26b24b5f9e49a9362.png", "tileimageuri": "https://productimages.withfloats.com/tile/662b94b26b24b5f9e49a9362.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-04-26T11:49:04.242Z", "updatedon": "2026-06-04T11:39:21.595Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//ticagrelor-90mg/763", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TICAGRACE 90", "category": "CARDIOLOGYRANGE", "tags": [ "ticagrelor 90 mg tablet", "ticagrelor 90 mg uses", "ticagrelor 90 mg price in india", "ticagrelor 90 mg dosage", "ticagrelor 90 mg side effects", "ticagrelor 90 mg composition", "buy ticagrelor 90 mg tablet online", "ticagrelor 90 mg tablet price", "how does ticagrelor 90 mg work", "ticagrelor 90 mg tablet benefits", "ticagrelor 90 mg mechanism of action", "ticagrelor 90 mg tablet in india", "what is ticagrelor 90 mg used for", "when to take ticagrelor 90 mg tablet" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6a50b1ae8f6638fa60654b85", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Bromfenac Ophthalmic Solution 0.09% w/v", "description": "Bromfenac ophthalmic solution 0.09% w/v is a prescription non-steroidal anti-inflammatory drug (NSAID) eye drop used primarily to treat pain and inflammation following cataract surgery and to reduce the risk of post-operative cystoid macular edema. Unlike corticosteroid eye drops, bromfenac is not a steroid — it works by inhibiting the cyclooxygenase (COX) enzyme, blocking the production of prostaglandins that drive inflammation, redness, and pain. A key advantage of bromfenac is its once-daily dosing, compared to the multiple daily doses required by many other topical NSAIDs and steroids, which improves ease of use during post-surgical recovery. Common side effects include mild burning or stinging on instillation and temporary blurred vision, while rare but serious risks include corneal complications with prolonged or inappropriate use. It is a Schedule H prescription-only medicine in India.\n\nWhat Is Bromfenac Ophthalmic Solution 0.09% w/v?\nBromfenac ophthalmic solution 0.09% w/v is a topical non-steroidal anti-inflammatory drug (NSAID) formulated for use in the eye. It is most commonly prescribed to manage inflammation and pain following ocular surgery, particularly cataract surgery, and is also used to help reduce the risk of post-operative cystoid macular edema, a swelling of the central retina that can occur after intraocular procedures.\nAs an NSAID, bromfenac differs fundamentally from corticosteroid eye drops. It does not carry the risk of raising intraocular pressure (IOP) that steroids do, making it a valuable option — often used alongside or instead of a steroid — in the post-surgical care protocol, depending on the surgeon's assessment.\nOne of bromfenac's most notable practical advantages is its once-daily dosing schedule, which sets it apart from several other ophthalmic NSAIDs that require two to four applications per day. This simplified regimen can improve patient adherence during the post-operative recovery period.\n\nHow Does Bromfenac Work? (Mechanism of Action)\n\nTissue injury response – Ocular surgery and inflammation trigger the release of arachidonic acid from damaged cell membranes.\nCyclooxygenase (COX) enzyme activity – The COX-1 and COX-2 enzymes convert arachidonic acid into prostaglandins, which are key mediators of inflammation, pain, and vascular permeability.\nCOX inhibition by bromfenac – Bromfenac inhibits both COX-1 and COX-2 enzymes, blocking the prostaglandin synthesis pathway.\nReduced inflammation and pain – With prostaglandin production suppressed, inflammation, redness, and post-surgical discomfort are reduced.\nProtection against macular edema – By limiting prostaglandin-driven vascular permeability, bromfenac also helps lower the risk of fluid accumulation in the macula following surgery.\n\n\nClinical Indications\nIndicationDetailsPost-operative inflammationPrimary use following cataract surgeryPost-operative pain managementReduces surgical site discomfort during recoveryPrevention of post-operative cystoid macular edemaUsed prophylactically around the time of cataract surgeryAdjunct to steroid therapySometimes used alongside corticosteroid drops for comprehensive post-surgical control\n\nDosage & Administration\nParameterRecommendationStandard doseOne drop in the operated eye, once dailyTimingOften started shortly before surgery and continued through the recovery period, as directedDurationTypically a defined post-operative course as prescribed by your ophthalmic surgeonContact lensesAvoid wearing contact lenses during the immediate post-operative period unless advised otherwiseMissed doseApply as soon as remembered; do not double the next doseCombination useMay be prescribed alongside antibiotic and/or steroid eye drops as part of a full post-surgical regimen — space applications as directed\nNote: Always follow your surgeon's specific pre- and post-operative dosing schedule, as timing around the surgery date is clinically important.\n\nKey Benefits\n\nEffectively reduces post-surgical pain and inflammation without the IOP-related risks of steroids\nOnce-daily dosing improves convenience and adherence compared to multi-dose NSAID or steroid regimens\nHelps lower the risk of post-operative cystoid macular edema, a potentially vision-affecting complication\nCan be used alongside steroid and antibiotic eye drops as part of a comprehensive post-surgical protocol\nGenerally does not raise intraocular pressure, unlike corticosteroid alternatives\nSupports a smoother, more comfortable post-operative recovery experience\n\n\nPrecautions\n\nUse strictly as directed by your ophthalmic surgeon, particularly regarding timing before and after surgery\nUse with caution in patients with known bleeding disorders or those taking medications that increase bleeding tendency, as NSAIDs can affect clotting\nRare but serious corneal complications (including delayed healing or, very rarely, corneal thinning) have been reported with prolonged or inappropriate NSAID use — report any unusual eye pain or vision change immediately\nNot recommended for patients with known hypersensitivity to bromfenac or other NSAIDs\nCaution advised in patients with complicated ocular surgeries, pre-existing corneal disease, or dry eye, as these may increase sensitivity to corneal side effects\nAvoid contact lens wear during the treatment period unless specifically advised by your doctor\nInform your doctor of all other eye medications and systemic drugs, especially blood thinners\n\n\nSide Effects\nCommon (Usually Mild and Temporary)\n\nMild burning or stinging sensation on instillation\nTemporary blurred vision\nEye redness\nEye discomfort or itching\n\nLess Common / Serious (Consult Your Doctor Promptly)\n\nPersistent or worsening eye pain\nDelayed corneal healing\nRare corneal complications, including corneal thinning or perforation with prolonged/inappropriate use\nIncreased risk of bleeding at the ocular surface in susceptible individuals\nSigns of an allergic reaction (swelling, itching, rash)\n\nDiscontinue and contact your ophthalmologist immediately if any serious or persistent symptom develops.\n\nComparison: Bromfenac vs. Other Post-Surgical Anti-Inflammatory Options\nTreatmentClassDosing FrequencyKey ConsiderationBromfenac ophthalmic solution 0.09%NSAIDOnce dailyConvenient dosing; no IOP risk; rare corneal risk with prolonged usePrednisolone acetateCorticosteroidMultiple times dailyEffective anti-inflammatory; carries IOP and cataract risk with prolonged useKetorolac ophthalmic solutionNSAIDMultiple times dailySimilar NSAID mechanism; more frequent dosing than bromfenacNepafenac ophthalmic suspensionNSAID (prodrug)1–3 times daily depending on formulationAlternative NSAID option; dosing varies by strength\n\nKey Statistics (Placeholder — Pending Clinical Reviewer Verification)\nMetricValueReported reduction in post-operative cystoid macular edema incidence with prophylactic NSAID use[Placeholder – insert verified clinical trial statistic]Typical duration of post-cataract-surgery bromfenac therapy[Placeholder – insert verified reference range]Reported rate of corneal adverse events with appropriate short-course use[Placeholder – insert epidemiological reference]\nAll statistics above are placeholders and must be verified and populated by a qualified clinical reviewer prior to publication.\n\nExpert Insight\n\n[Placeholder — Expert quote pending. To be added only after review and approval by a licensed ophthalmologist/medical reviewer associated with Steris Healthcare. Do not fabricate or publish without sign-off.]\n\n\nPrice of Bromfenac Ophthalmic Solution 0.09% w/v\nThe price of bromfenac ophthalmic solution 0.09% w/v varies depending on brand, pack size, and region. For current pricing, availability, and prescription verification, please consult your ophthalmologist or an authorized pharmacy.\nPrescription only – consult your doctor.\n\nConclusion\nBromfenac ophthalmic solution 0.09% w/v has become a widely used part of modern post-cataract-surgery care, offering effective pain and inflammation control along with a meaningful reduction in the risk of post-operative cystoid macular edema — all with the convenience of once-daily dosing. As an NSAID rather than a steroid, it avoids the intraocular pressure concerns associated with corticosteroid therapy, though it carries its own specific precautions, particularly around rare corneal complications with prolonged or inappropriate use. Used exactly as directed by your ophthalmic surgeon, within the prescribed post-operative window, bromfenac supports a smoother, more comfortable surgical recovery.\n\nFrequently Asked Questions\n\n1. What is bromfenac ophthalmic solution 0.09% used for?\nIt is used to treat pain and inflammation following cataract surgery and to help reduce the risk of post-operative cystoid macular edema, a swelling of the central retina that can occur after eye surgery.\n\n2. Is bromfenac a steroid?\nNo. Bromfenac is a non-steroidal anti-inflammatory drug (NSAID). It works by inhibiting the cyclooxygenase (COX) enzyme rather than acting through the steroid pathway, and it does not carry the intraocular pressure risks associated with corticosteroids.\n\n3. How often should bromfenac eye drops be used?\nBromfenac ophthalmic solution 0.09% is typically used once daily in the operated eye, making it more convenient than many other post-surgical eye drops that require multiple daily doses.\n\n4. How long is bromfenac used after cataract surgery?\nThe duration is determined by your ophthalmic surgeon based on your individual recovery, often continuing through a defined post-operative period as part of your overall surgical care protocol.\n\n5. Can bromfenac be used with steroid eye drops?\nYes, bromfenac is often prescribed alongside corticosteroid and/or antibiotic eye drops as part of a comprehensive post-surgical regimen, with applications spaced as directed by your doctor.\n\n6. What are the side effects of bromfenac eye drops?\nCommon side effects include mild burning or stinging upon application, temporary blurred vision, and eye redness. Rare but serious effects can include delayed corneal healing or corneal complications with prolonged or inappropriate use.\n\n7. Does bromfenac raise eye pressure?\nNo, as an NSAID, bromfenac does not typically raise intraocular pressure the way corticosteroid eye drops can, which is one of its key advantages in post-surgical care.\n\n8. Can bromfenac cause corneal problems?\nRare but serious corneal complications, including delayed healing or corneal thinning, have been reported with prolonged or inappropriate NSAID use. Any unusual eye pain or vision change should be reported to your doctor immediately.\n\n9. Is bromfenac safe for people on blood thinners?\nNSAIDs like bromfenac can affect bleeding tendency, so patients on blood-thinning medications or with known bleeding disorders should inform their doctor before starting treatment.\n10. Can contact lenses be worn while using bromfenac?\nIt is generally advised to avoid wearing contact lenses during the post-operative treatment period unless your ophthalmologist specifically advises otherwise.\n11. What happens if I miss a dose of bromfenac?\nApply the missed dose as soon as you remember, unless it is nearly time for your next scheduled dose, in which case skip the missed dose. Do not double up doses.\n12. How is bromfenac different from ketorolac eye drops?\nBoth are NSAIDs with a similar mechanism of action, but bromfenac typically requires only once-daily dosing, while ketorolac usually requires multiple applications per day.\n13. Can bromfenac prevent macular edema after cataract surgery?\nBromfenac is commonly used prophylactically around the time of cataract surgery to help reduce the risk of post-operative cystoid macular edema, a recognized complication of intraocular surgery.\n\n14. Is bromfenac safe for long-term use?\nBromfenac is generally prescribed for a defined post-operative course rather than continuous long-term use, and prolonged or unsupervised use should be avoided due to rare corneal risks.\n\n15. Who should not use bromfenac eye drops?\nPatients with known hypersensitivity to bromfenac or other NSAIDs, or those with certain pre-existing corneal or bleeding conditions, should use bromfenac only under close medical supervision, if at all.\n\n16. Does bromfenac cause blurred vision?\nTemporary blurred vision can occur immediately after instillation in some patients and usually resolves quickly. Persistent blurred vision should be reported to your doctor.\n\n17. Can bromfenac be used before cataract surgery as well as after?\nYes, bromfenac is often started shortly before surgery and continued through the post-operative recovery period, following the specific schedule set by your ophthalmic surgeon.\n", "price": 195.0, "discountamount": 136.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2472, "imageuri": "https://productimages.withfloats.com/actual/6a50b1b32d7a16f0f95be110.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a50b1b32d7a16f0f95be110.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-07-10T08:47:42.715Z", "updatedon": "2026-07-10T08:47:42.715Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//bromfenac-ophthalmic-solution-0-09-w-v/2472", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CIPVISION BROMAXIS 0.09%", "category": "Opthalmology Range", "tags": [ "Bromfenac Ophthalmic Solution 0.09% w/v", "bromfenac ophthalmic solution 0.09%" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a5092283075a19d4f2db6bd", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Cyclosporine Eye Drops 0.05% w/v", "description": "Cyclosporine eye drops 0.05% are a prescription ophthalmic emulsion used to treat chronic dry eye disease (keratoconjunctivitis sicca) caused by ocular surface inflammation. Unlike lubricating tear substitutes that only manage symptoms, cyclosporine works as a calcineurin-inhibitor immunomodulator that calms the underlying inflammation suppressing your eyes' natural tear production. It is not a steroid. The standard dose is one drop in each affected eye, twice daily, about 12 hours apart, and visible improvement in tear production typically takes 6–12 weeks, with full benefit sometimes taking up to 3–6 months of consistent use. Common side effects include temporary burning, stinging, redness, and watery eyes at the time of instillation. It is a Schedule H prescription-only medicine in India and should be used only under a qualified ophthalmologist's guidance.\n\nWhat Is Cyclosporine Eye Drops 0.05%?\nCyclosporine eye drops 0.05% (ophthalmic emulsion) is a prescription formulation designed to manage chronic dry eye disease, a condition in which the eyes fail to produce enough tears or produce tears of poor quality, often because of an underlying inflammatory process on the ocular surface and in the lacrimal (tear-producing) gland.\nThis formulation is commonly prescribed for patients whose dry eye is presumed to be due to ocular inflammation — for example, those with moderate to severe dry eye, keratoconjunctivitis sicca, or dry eye associated with conditions like Sjögren's syndrome, that has not responded adequately to artificial tears alone.\nCyclosporine belongs to a class of drugs called calcineurin inhibitors. It differs fundamentally from corticosteroid eye drops, which suppress inflammation broadly and carry risks like raised intraocular pressure and cataract formation with long-term use. Cyclosporine instead selectively dampens the T-cell-mediated inflammatory response that is thought to suppress tear gland function, allowing the eye's own tear-producing mechanism to gradually recover.\n\nHow Do Cyclosporine Eye Drops Work? (Mechanism of Action)\n\nInflammation on the ocular surface – In chronic dry eye, T-lymphocytes infiltrate the conjunctiva and lacrimal gland, triggering a self-perpetuating inflammatory cycle.\nCalcineurin inhibition – Cyclosporine binds to a cellular protein (cyclophilin) and blocks calcineurin, an enzyme required to activate T-cells.\nReduced T-cell activation – With calcineurin blocked, T-cells cannot produce the inflammatory signals (such as interleukin-2) that damage the lacrimal gland and conjunctival tissue.\nRestoration of tear production – As local inflammation subsides over weeks to months, the lacrimal gland's ability to produce natural tears gradually improves.\nImproved tear film stability – With reduced inflammation and increased natural tear volume, patients typically notice less dryness, grittiness, and ocular surface damage over time.\n\nThis is why cyclosporine drops are described as disease-modifying for dry eye rather than purely symptomatic — they address a root inflammatory cause instead of simply lubricating the eye.\n\nClinical Indications\nIndicationDetailsChronic dry eye disease (keratoconjunctivitis sicca)Primary approved use; especially where tear production is suppressed due to ocular inflammationModerate to severe dry eye not controlled by artificial tearsSecond-line option when lubricants alone are insufficientDry eye associated with autoimmune conditionsE.g., Sjögren's syndrome-related dry eye, under specialist supervisionPost-refractive surgery dry eye (select cases)Sometimes used off-label under ophthalmologist guidance\n\nDosage & Administration\nParameterRecommendationStandard doseOne drop in each affected eye, twice dailyDosing intervalApproximately 12 hours apartContact lens useRemove lenses before instillation; wait at least 15 minutes before reinsertingOnset of noticeable effectUsually 6–12 weeksFull therapeutic benefitMay take up to 3–6 months of continuous useMissed doseContinue with next scheduled dose; do not double upDiscontinuationOnly under medical advice — symptoms may return if stopped prematurely\nNote: Cyclosporine eye drops are for long-term, continuous use as directed by your ophthalmologist. Improvement is gradual, not immediate, and consistent daily use is essential for benefit.\n\nKey Benefits\n\nTargets the underlying inflammatory cause of chronic dry eye rather than only masking symptoms\nCan increase natural tear production over sustained use\nGenerally well tolerated for long-term use, since it is not a steroid and does not carry steroid-related risks like elevated eye pressure or cataract with routine use\nMay reduce dependence on frequent artificial tear instillation over time\nSuitable for long-term maintenance therapy in chronic, relapsing dry eye disease\nCan improve comfort during visually demanding tasks (screen use, reading, driving) affected by chronic dryness\n\n\nPrecautions\n\nUse strictly as prescribed by an ophthalmologist; do not self-medicate\nNot intended for immediate relief of dry eye symptoms — artificial tears may be used concurrently for interim comfort as advised by your doctor\nShould not be used in the presence of an active ocular infection unless specifically directed by a physician\nInform your doctor if you are pregnant, breastfeeding, or have any known hypersensitivity to cyclosporine or emulsion components\nAvoid touching the dropper tip to the eye or any surface to prevent contamination\nIf wearing contact lenses, remove before application and reinsert only after 15 minutes\nDo not use expired or previously opened single-use vials, if applicable to your product format\nRegular ophthalmic follow-up is recommended to monitor treatment response\n\n\nSide Effects\nCommon (Usually Mild and Temporary)\n\nBurning or stinging sensation upon instillation\nEye redness\nWatery eyes (excessive tearing)\nEye discomfort or a feeling of something in the eye\nTemporary blurred vision immediately after application\n\nLess Common / Serious (Consult Your Doctor Promptly)\n\nPersistent or worsening eye pain\nSigns of eye infection (discharge, significant redness, swelling)\nVisual disturbance that does not resolve\nSigns of an allergic reaction (eyelid swelling, itching, rash)\n\nIf any serious or persistent symptom occurs, discontinue use and consult your ophthalmologist immediately.\n\nComparison: Cyclosporine Eye Drops vs. Other Dry Eye Treatments\nTreatmentMechanismOnset of ActionLong-Term Use ProfileCyclosporine 0.05% dropsCalcineurin inhibitor; reduces inflammation, restores natural tear productionWeeks to monthsGenerally suitable for continuous long-term useArtificial tears / lubricantsSymptomatic lubrication onlyImmediate, short-livedSafe but does not address inflammation; frequent reapplication neededCorticosteroid eye dropsBroad anti-inflammatory actionFast (days)Not recommended for long-term use due to risk of raised IOP, cataractLifitegrast ophthalmic solutionLFA-1 antagonist; blocks a different inflammatory pathwayWeeksAlternative option, mechanism differs from cyclosporine\n\nKey Statistics (Placeholder — Pending Clinical Reviewer Verification)\nMetricValueReported patients showing improved tear production at 6 months[Placeholder – insert verified clinical trial statistic]Prevalence of chronic dry eye disease in adults[Placeholder – insert epidemiological reference]Average time to symptomatic improvement[Placeholder – insert verified reference range]\nAll statistics above are placeholders and must be verified and populated by a qualified clinical reviewer prior to publication.\n\nExpert Insight\n\n[Placeholder — Expert quote pending. To be added only after review and approval by a licensed ophthalmologist/medical reviewer associated with Steris Healthcare. Do not fabricate or publish without sign-off.]\n\n\nPrice of Cyclosporine Eye Drops 0.05%\nThe price of cyclosporine eye drops 0.05% varies depending on pack size, brand, and region. For current pricing, availability, and prescription verification, please consult your ophthalmologist or authorized pharmacy.\nPrescription only – consult your doctor.\n\nConclusion\nCyclosporine eye drops 0.05% represent a meaningful shift in how chronic dry eye disease is managed — moving beyond temporary lubrication to address the underlying inflammatory process that suppresses natural tear production. For patients with moderate to severe dry eye that hasn't responded well to artificial tears alone, this calcineurin-inhibitor therapy offers a disease-modifying option that, with consistent long-term use, can meaningfully improve ocular comfort and tear film health. Because benefits build gradually over weeks to months, patience and adherence to the prescribed twice-daily regimen are essential. As with any prescription ophthalmic therapy, cyclosporine eye drops should only be used under the guidance of a qualified ophthalmologist, who can confirm suitability, monitor progress, and adjust care as needed.\n\nFrequently Asked Questions\n\n1. What are cyclosporine 0.05% eye drops used for?\nCyclosporine 0.05% eye drops are used to treat chronic dry eye disease caused by ocular surface inflammation. They help increase natural tear production in patients whose tear glands are suppressed due to inflammation, particularly when artificial tears alone aren't enough.\n\n2. How long can I use cyclosporine eye drops?\nCyclosporine eye drops are typically used long-term, as chronic dry eye is an ongoing condition. Many patients continue therapy for months to years under regular ophthalmologist supervision, since symptoms can return if the medication is stopped.\n\n3. Is Cyclomune a steroid?\nNo. Cyclomune (a brand of cyclosporine ophthalmic emulsion) is not a steroid. It is a calcineurin-inhibitor immunomodulator that works differently from steroid eye drops and does not carry the same risk of raised eye pressure or cataract associated with long-term steroid use.\n4. How quickly do cyclosporine eye drops start working?\nMost patients begin noticing improvement in tear production and dry eye symptoms within 6 to 12 weeks, though full benefit may take up to 3 to 6 months of consistent, twice-daily use.\n\n5. Can cyclosporine damage eyes?\nWhen used exactly as prescribed, cyclosporine eye drops are generally considered safe for long-term use. Temporary burning, stinging, or watering can occur at the time of instillation, but serious eye damage is uncommon. Any persistent pain, vision changes, or signs of infection should be reported to your ophthalmologist promptly.\n\n6. How much are cyclosporine 0.05% eye drops?\nPricing varies by brand, pack size, and region. Since this is a prescription-only medicine, please check current pricing with your prescribing doctor or a licensed pharmacy.\n\n7. Is cyclosporine a steroid?\nNo. Cyclosporine is a calcineurin inhibitor, a category of immunomodulating medication that is pharmacologically distinct from corticosteroids (steroids), even though both can reduce inflammation.\n\n8. Can I wear contact lenses while using cyclosporine eye drops?\nContact lenses should be removed before applying the drops and can typically be reinserted after about 15 minutes, unless your ophthalmologist gives different instructions.\n9. What happens if I stop using cyclosporine eye drops suddenly?\nStopping suddenly may cause dry eye symptoms to gradually return, since the underlying inflammation is no longer being managed. Always consult your doctor before discontinuing treatment.\n\n10. Can cyclosporine eye drops be used with artificial tears?\nYes, in many cases artificial tears can be used alongside cyclosporine drops for additional comfort, especially during the initial weeks before cyclosporine's full effect develops. Confirm timing and spacing with your doctor.\n\n11. Who should not use cyclosporine eye drops?\nPatients with known hypersensitivity to cyclosporine or its components, active untreated eye infections, or specific contraindications identified by their doctor should not use this medication without medical clearance.\n\n12. Are cyclosporine eye drops safe during pregnancy?\nUse during pregnancy or breastfeeding should only occur under medical supervision. Inform your doctor if you are pregnant, planning pregnancy, or breastfeeding before starting treatment.\n\n13. What is the difference between cyclosporine eye drops and lubricating eye drops?\nLubricating (artificial tear) drops provide temporary symptomatic relief by adding moisture to the eye, while cyclosporine drops target the underlying inflammation responsible for reduced natural tear production, offering a longer-term, disease-modifying approach.\n\n14. Can children use cyclosporine eye drops?\nUse in children should only be under the direct guidance and prescription of a pediatric ophthalmologist, based on individual clinical assessment.\n\n15. Do cyclosporine eye drops cause blurred vision?\nTemporary blurred vision can occur immediately after instillation in some patients. This usually resolves quickly. If blurred vision persists, consult your doctor.\n\n16. Can cyclosporine eye drops be used with other eye medications?\nOther eye medications, including other prescription drops, should only be combined with cyclosporine under your ophthalmologist's guidance, with appropriate spacing between different drops.\n\n17. Why do cyclosporine eye drops take so long to work?\nBecause cyclosporine works by gradually reducing chronic inflammation in the lacrimal gland and ocular surface rather than providing instant lubrication, visible improvement in natural tear production takes weeks to months rather than being immediate.", "price": 495.0, "discountamount": 149.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2468, "imageuri": "https://productimages.withfloats.com/actual/6a50922a464ced2a630398a1.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a50922a464ced2a630398a1.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-07-10T06:33:12.096Z", "updatedon": "2026-07-10T06:33:12.096Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//cyclosporine-eye-drops-0-05-w-v/2468", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CIPVISION CYCLOPURE 0.5 mg", "category": "Opthalmology Range", "tags": [ "Cyclosporine Eye Drops 0.05% w/v", "cyclosporine eye drops", "cyclosporine eye drops uses", "cyclosporine eye drops ip 0.05 w/v", "cyclosporine eye drops price", "cyclosporine eye drops uses in hindi", "cyclosporine eye drops side effects", "cyclosporine eye drops 0.05", "cyclosporine eye drops brand name", "cyclosporine eye drops india" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a4cf84af44be73628317db4", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "ketorolac tromethamine ofloxacin eye drops", "description": "Ketorolac tromethamine ofloxacin eye drops are a prescription combination formulation that pairs an NSAID (ketorolac tromethamine) with a fluoroquinolone antibiotic (ofloxacin) in a single ophthalmic solution. Ketorolac reduces pain, inflammation, and irritation, while ofloxacin treats or prevents bacterial eye infections — making this combination especially useful after eye surgery, such as cataract or corneal refractive procedures, when both inflammation control and infection prevention are needed at the same time. It's generally well tolerated, with mild stinging or burning being the most common effect, and should only be used exactly as prescribed by an eye care professional.\nWhat Is Ketorolac Tromethamine Ofloxacin Eye Drops?\nThis is a fixed-dose combination ophthalmic solution bringing together two distinct classes of medication:\n\nKetorolac tromethamine — a nonsteroidal anti-inflammatory drug (NSAID) that blocks prostaglandin synthesis in the eye, reducing pain, inflammation, and irritation\nOfloxacin — a fluoroquinolone antibiotic that treats bacterial infections of the eye, including conjunctivitis and corneal ulcers, by inhibiting bacterial DNA replication\n\nCombining the two addresses two separate clinical needs at once: controlling post-operative or allergy-related inflammation, and reducing the risk of bacterial infection during the eye's vulnerable healing period. This combination is commonly prescribed following cataract surgery, corneal refractive surgery, and other ocular procedures where both inflammation and infection risk need to be managed together.\nHow This Combination Works (Mechanism of Action)\n\nKetorolac's anti-inflammatory action — Blocks the cyclooxygenase (COX) enzyme pathway, reducing the production of prostaglandins, the chemical messengers responsible for pain, redness, and swelling in the eye.\nReduced pain and irritation — With prostaglandin production suppressed, patients experience less post-surgical discomfort, itching, and burning.\nOfloxacin's antibacterial action — Inhibits bacterial DNA gyrase and topoisomerase IV, enzymes bacteria need to replicate their DNA, effectively stopping bacterial growth.\nInfection prevention/control — By suppressing bacterial replication, ofloxacin helps prevent or treat infections that could otherwise complicate the eye's healing process after surgery or injury.\nCombined post-operative support — Together, the two components address both major risks during ocular recovery: uncontrolled inflammation and secondary bacterial infection.\n\nClinical Indications\nUse CaseRole of the CombinationPost-cataract surgery careControls inflammation and pain while preventing bacterial infection during healingPost-corneal refractive surgery (e.g., LASIK)Reduces post-operative discomfort and infection riskBacterial conjunctivitis with inflammationTreats the underlying infection while easing associated redness and irritationCorneal injury or minor trauma (as directed)Supports healing by addressing both inflammation and infection riskSeasonal allergic conjunctivitis (ketorolac component)Relieves itching associated with seasonal eye allergies\nThis combination is intended for short-term, doctor-directed use — not for long-term or repeated self-administration.\nDosage Guidelines\nParameterTypical GuidanceStandard doseOne drop in the affected eye(s), frequency as prescribed by your doctorCommon frequencyOften 2 to 4 times daily, depending on the condition being treated and product-specific labelingPost-surgical useUsually started shortly after surgery and continued for a defined post-operative period, as directedAdministration techniqueTilt head back, pull down the lower eyelid, instill the drop without touching the dropper tip to the eye, then close the eye gently for a minute or twoContact lens useAvoid wearing contact lenses during treatment unless your doctor says otherwiseDurationComplete the full prescribed course, even if symptoms improve early, to reduce the risk of antibiotic resistance or incomplete healing\nExact dosing frequency and treatment duration vary by brand formulation and the specific condition being treated — always follow your prescribing doctor's exact instructions rather than a generic schedule.\nKey Benefits\n\nAddresses two major post-surgical risks — inflammation/pain and bacterial infection — in a single combination product\nReduces the need for two separate eye drop bottles, simplifying the post-operative care routine\nKetorolac's anti-inflammatory action helps improve comfort during the critical early healing window after eye surgery\nOfloxacin's broad-spectrum antibacterial activity covers many common eye pathogens\nUseful for both surgical recovery and certain inflammatory/infectious conditions like allergic or bacterial conjunctivitis with associated discomfort\n\nPrecautions\n\nShould be used strictly under the guidance of an ophthalmologist — not for self-directed or prolonged use\nDo not use alongside other NSAID eye drops, as this can increase the risk of bleeding and delayed healing\nUse with caution alongside steroid-containing eye drops, as combined use may increase infection risk\nUse with caution in patients who bleed easily or are on blood-thinning medication, due to ketorolac's NSAID effects\nIf symptoms do not improve within the expected timeframe, or worsen, contact your doctor rather than continuing use independently\nAvoid contact lens wear during treatment unless specifically advised otherwise\nDiscontinue immediately and contact your doctor at the first sign of a rash or allergic reaction\nNot recommended for infants under 1 year old (based on the ofloxacin component's approved age range)\n\nSide Effects\nCommon side effects:\n\nStinging or burning on application\nTemporary blurred vision\nEye redness or irritation\nDryness or excess tearing\nSensitivity to light (photophobia)\n\nLess common side effects:\n\nItching or foreign body sensation in the eye\nEyelid swelling\nMild headache\n\nRare but serious side effects — seek immediate medical attention:\n\nSigns of an allergic reaction: hives, difficulty breathing, swelling of the face, lips, tongue, or throat\nSevere skin reaction: fever, sore throat, facial or tongue swelling, skin pain followed by a spreading red or purple rash with blistering\nCorneal problems: persistent eye pain, corneal thinning, erosion, or non-healing of the eye surface\nWorsening infection symptoms despite treatment\n\nMost side effects are mild and temporary; however, any signs of a serious allergic or corneal reaction require prompt medical attention.\nComparison with Alternatives\nFeatureKetorolac + Ofloxacin CombinationSteroid + Antibiotic Combination (e.g., Dexamethasone + Tobramycin)Anti-inflammatory mechanismNSAID (COX inhibition)Corticosteroid (broader immune suppression)Infection risk with prolonged useLower relative infection-masking riskHigher risk of masking infection with prolonged steroid useTypical use casePost-operative pain/inflammation with infection preventionBroader inflammatory eye conditions requiring stronger anti-inflammatory controlIntraocular pressure effectMinimal IOP effect from ketorolacSteroids can raise intraocular pressure with prolonged use\nYour ophthalmologist will select the combination best suited to your specific procedure, condition, and risk factors.\nKey Statistics\n[Placeholder — pending clinical/regulatory team verification. Do not publish without confirmed source citation for post-operative infection rate reduction data, comparative efficacy figures, or incidence rates of reported adverse effects for this specific combination product.]\nExpert Insight\n[Placeholder — reserved for a quote from a qualified ophthalmologist or clinical reviewer. Do not publish without a verified, attributable expert quote.]\nFrequently Asked Questions\n1. What is ketorolac and ofloxacin eye drops used for?\nThis combination is used to control pain, inflammation, and irritation while also preventing or treating bacterial infection in the eye — most commonly after cataract or corneal refractive surgery, and sometimes for infected, inflamed conditions like bacterial conjunctivitis.\n2. Is ketorolac eye drops safe to use?\nKetorolac eye drops are generally safe when used as prescribed by a doctor for approved indications like post-surgical inflammation or allergic conjunctivitis. As with any NSAID, it should be used with caution in people who bleed easily or take blood thinners, and not combined with other NSAID eye drops.\n3. Is ofloxacin safe for eyes?\nYes, ofloxacin eye drops are considered safe and are widely prescribed for bacterial eye infections when used as directed. Common effects are mild and temporary, such as stinging or light sensitivity; serious reactions are rare but should be reported to a doctor immediately if they occur.\n4. Is ketorolac safe for eyes?\nKetorolac eye drops are safe for ophthalmic use when prescribed appropriately and used according to your doctor's instructions. It's an established NSAID with a long history of use for post-surgical pain and allergic conjunctivitis, though it requires caution in certain patients, such as those with bleeding disorders.\n5. How many times a day can you use ketorolac eye drops?\nThis depends on the condition being treated and your doctor's specific prescription — commonly this is 2 to 4 times daily. Always follow your doctor's exact dosing instructions rather than a generic schedule, since frequency varies by indication and product.\n6. Does ketorolac reduce eye pressure?\nNo, ketorolac is not used to reduce intraocular eye pressure. It works as an anti-inflammatory pain reliever by blocking prostaglandin production, not as a pressure-lowering agent. Medications specifically designed to reduce eye pressure, such as those used in glaucoma, work through different mechanisms and are a separate category of treatment.\nConclusion\nKetorolac tromethamine ofloxacin eye drops offer a practical, combined solution for two of the most important concerns during eye recovery: controlling inflammation and pain, and preventing bacterial infection. By pairing an established NSAID with a trusted fluoroquinolone antibiotic, this combination simplifies post-operative care, particularly after cataract or corneal refractive surgery, while addressing allergic and infectious inflammatory conditions when appropriate. Most side effects are mild and temporary, though the combination should always be used exactly as prescribed, with attention to precautions around other eye medications, bleeding risk, and contact lens use. As with any prescription ophthalmic treatment, ongoing follow-up with your ophthalmologist ensures the medication is working as intended and any concerns are addressed early.", "price": 90.0, "discountamount": 27.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2467, "imageuri": "https://productimages.withfloats.com/actual/6a4cf84ca50a3eb7ed21b13b.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a4cf84ca50a3eb7ed21b13b.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-07-07T12:59:54.142Z", "updatedon": "2026-07-07T12:59:54.142Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//ketorolac-tromethamine-ofloxacin-eye-drops/2467", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CIPVISION KEYPROFEN OFLA", "category": "Opthalmology Range", "tags": [ "ketorolac tromethamine ofloxacin eye drops", "ketorolac tromethamine", "ketorolac tromethamine uses", "ketorolac tromethamine uses in hindi", "ketorolac tromethamine dispersible tablets uses in hindi", "ketorolac tromethamine tablet uses in hindi", "ketorolac tromethamine use in hindi", "ketorolac tromethamine use" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "69f9caa4e32cd06b842dfa21", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Brimonidine Tartrate Eye Drops IP 0.2 W/V", "description": "Brimonidine Tartrate Eye Drops IP 0.2% w/v – Complete Buyer Intent Guide\n\nIf you’re looking for a reliable and clinically proven solution to control elevated eye pressure and protect your vision, Brimonidine Tartrate Eye Drops IP 0.2% w/v are a widely prescribed and effective option. Designed specifically for patients with glaucoma or ocular hypertension, this medication helps reduce intraocular pressure (IOP), lowering the risk of optic nerve damage and vision loss. This buyer-focused guide will walk you through everything you need to know before purchasing—ensuring informed, confident decisions.\n\nWhat is Brimonidine Tartrate Eye Drops IP 0.2% w/v?\n\nBrimonidine Tartrate Eye Drops IP 0.2% w/v is a prescription ophthalmic solution used to lower increased pressure inside the eye. It belongs to a class of drugs known as alpha-2 adrenergic receptor agonists, which act directly on the eye’s fluid dynamics.\n\nElevated intraocular pressure is a major cause of glaucoma, a serious eye condition that can lead to irreversible blindness if not treated properly. Brimonidine is commonly recommended either as a standalone therapy or in combination with other eye drops for better pressure control.\n\nHow Does Brimonidine Tartrate Work?\n\nBrimonidine works through a dual mechanism of action, making it highly effective:\n\n1. Reduces Aqueous Humor Production\n\nIt decreases the amount of fluid produced inside the eye, lowering pressure.\n\n2. Increases Uveoscleral Outflow\n\nIt improves the drainage of fluid from the eye, preventing buildup.\n\nThis combination helps maintain optimal eye pressure levels, protecting the optic nerve and preserving vision over time.\n\nWhat Conditions Does It Treat?\n\nBrimonidine Tartrate Eye Drops IP 0.2% w/v is primarily used for:\n\n✔ Open-Angle Glaucoma\n\nThe most common type of glaucoma, characterized by gradual pressure buildup.\n\n✔ Ocular Hypertension\n\nA condition where eye pressure is elevated without visible damage yet.\n\n✔ Adjunct Therapy\n\nUsed along with other medications like beta-blockers when additional pressure reduction is needed.\n\nKey Benefits of Brimonidine Tartrate Eye Drops\n\nWhen evaluating treatment options, here’s why Brimonidine stands out:\n\n✔ Effective IOP Reduction\n\nClinically proven to significantly lower intraocular pressure.\n\n✔ Dual Action Formula\n\nTargets both fluid production and drainage for better results.\n\n✔ Neuroprotective Potential\n\nMay help protect optic nerve cells from damage (under ongoing research).\n\n✔ Convenient Dosage\n\nTypically used 2–3 times daily, making it manageable for long-term therapy.\n\n✔ Suitable for Combination Therapy\n\nWorks well with other glaucoma medications for enhanced effectiveness.\n\nHow to Use Brimonidine Tartrate Eye Drops\n\nProper application is essential for best results.\n\nStep-by-Step Instructions:\nWash your hands thoroughly\nTilt your head backward\nPull down the lower eyelid to form a pocket\nHold the dropper above the eye\nInstill one drop into the affected eye\nClose your eyes gently for 1–2 minutes\nAvoid touching the dropper tip\nDosage Guidelines:\nUsually 1 drop in the affected eye(s), 2–3 times daily\nFollow your doctor’s instructions strictly\nDo not skip doses or stop suddenly\nWho Should Use This Medication?\n\nBrimonidine Tartrate Eye Drops are ideal for:\n\nPatients diagnosed with glaucoma\nIndividuals with elevated intraocular pressure\nThose requiring additional pressure control alongside other treatments\n\nNote: Always use under medical supervision.\n\nPossible Side Effects\n\nWhile generally well tolerated, some side effects may occur.\n\nCommon Side Effects:\nEye redness or irritation\nDry mouth\nBurning or stinging sensation\nBlurred vision temporarily\nLess Common but Serious Effects:\nLow blood pressure\nFatigue or drowsiness\nAllergic reactions\nEye inflammation\n\nIf symptoms persist or worsen, consult a healthcare professional immediately.\n\nPrecautions and Warnings\n\nBefore buying or using Brimonidine Tartrate Eye Drops IP 0.2% w/v, consider the following:\n\nAvoid Use If:\nYou are allergic to Brimonidine\nYou are taking MAO inhibitors (certain antidepressants)\nUse With Caution If:\nYou have cardiovascular disease\nYou experience low blood pressure\nYou have depression\nYou are pregnant or breastfeeding\nSafety Tips:\nRemove contact lenses before use\nWait at least 10–15 minutes before reinserting lenses\nAvoid driving immediately after use if vision is blurred\nDrug Interactions\n\nBrimonidine may interact with:\n\nAntidepressants (MAO inhibitors, tricyclics)\nBlood pressure medications\nCNS depressants (may increase drowsiness)\n\nAlways inform your doctor about all medications you are currently taking.\n\nStorage Instructions\nStore in a cool, dry place\nProtect from direct sunlight\nDo not freeze\nKeep the bottle tightly closed\nKeep out of reach of children\nWhy Choose Brimonidine Tartrate Eye Drops IP 0.2% w/v?\n\nFrom a buyer’s perspective, this medication offers several advantages:\n\nProven efficacy in lowering eye pressure\nDual-action mechanism for better control\nSuitable for long-term glaucoma management\nWidely recommended by ophthalmologists\nCost-effective compared to advanced therapies\n\nIt is a dependable choice for maintaining eye health and preventing vision complications.\n\nBuying Guide – What to Check Before Purchase\n\nBefore purchasing Brimonidine Tartrate Eye Drops, ensure:\n\nIt meets IP (Indian Pharmacopoeia) standards\nThe packaging is sealed and tamper-proof\nThe expiry date is valid\nIt is sourced from a trusted pharmaceutical brand\nStorage conditions have been properly maintained\n\nBuying from a reputable supplier ensures product authenticity and safety.\n\nConclusion\n\nBrimonidine Tartrate Eye Drops IP 0.2% w/v is a highly effective and trusted treatment for managing intraocular pressure in patients with glaucoma or ocular hypertension. Its dual-action approach, ease of use, and strong safety profile make it a preferred choice for both patients and healthcare providers.", "price": 260.0, "discountamount": 78.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2403, "imageuri": "https://productimages.withfloats.com/actual/69f9cadfcb1bdeb7ff24d5a5.png", "tileimageuri": "https://productimages.withfloats.com/tile/69f9cadfcb1bdeb7ff24d5a5.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-05-05T10:47:00.988Z", "updatedon": "2026-06-05T06:47:20.7Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//brimonidine-tartrate-eye-drops-ip-0-2-w-v/2403", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CIPVISION BRIMLIFE 0.2%", "category": "Opthalmology Range", "tags": [ "Brimonidine Tartrate Eye Drops IP 0.2 W/V", "brimonidine tartrate eye drops", "brinzolamide and brimonidine tartrate eye drops", "brimonidine tartrate eye drops uses in hindi", "brimonidine tartrate eye drops price", "brimonidine tartrate eye drops uses", "brimonidine tartrate eye drops ip 0.2 w/v", "brimonidine tartrate eye drops ip", "brimonidine tartrate eye drops ip 0.15%", "buy brimonidine tartrate eye drops", "brimonidine tartrate eye drops dosage", "brimonidine tartrate eye drops dosage", "brimonidine tartrate eye drops in hindi", "brimonidine tartrate eye drops packaging", "brimonidine tartrate eye drops ip 0.1 w/v", "Brimonidine tartrate and timolol eye drops", "Brimonidine Tartrate Timolol Maleate Eye Drops Price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }